
    
      All participants will receive five vaccine injections, i.e. one at Day 0, at Day 3, at Day 7,
      at Day 14 and at Day 28, respectively, (Essen regimen). In addition, human rabies
      immunoglobulins (HRIG) will be concomitantly administered to all subjects on Day 0.

      Safety will be assessed in all participants up to 28 days after vaccination, as applicable,
      in terms of occurrence of adverse events (AEs), and serious adverse events (SAEs) and adverse
      events of special interest (AESIs) up to 6 months post-vaccination 5.
    
  